Logo_arpbig_fondo_transparente_colores_blanco_letras_blanco
fernando
Interplay between Peptidoglycan Biology and Virulence in Gram-Negative Pathogens.
By fernando | | 0 Comments |
Juan C1, Torrens G1, Barceló IM1, Oliver A1 1Hospital Universitario…
Deciphering β-lactamase-independent β-lactam resistance evolution trajectories in Pseudomonas aeruginosa.
By fernando | | 0 Comments |
Cabot G1, Florit-Mendoza L1, Sánchez-Diener I1, Zamorano L1, Oliver A1…
41st European Cystic Fibrosis (ECFS) Conference Attendance
By fernando | | 0 Comments |
We will be attending to the 41st European Cystic Fibrosis…
22nd Congress of Spanish Society for Infectious Diseases and Clinic Microbiology (SEIMC) Attendance
By fernando | | 0 Comments |
We will be attending to the 22nd Congress of Spanish…
28th ECCMID Digital Poster Versions
By fernando | | 0 Comments |
Here you can find the Posters we present in 28th…
28th ECCMID Attendance
By fernando | | 0 Comments |
We will be attending to the 28th European Congress of…
Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae.
By fernando | | 0 Comments |
Scheuerman O1, Schechner V1, Carmeli Y1, Gutiérrez-Gutiérrez B2, Calbo E3,…
Optimization of a meropenem plus tobramycin combination dosage regimen against hypermutable and non-hypermutable Pseudomonas aeruginosa via mechanism-based modeling and the hollow-fiber infection model.
By fernando | | 0 Comments |
Landersdorfer CB1,2, Rees VE3,2, Yadav R3, Rogers KE3,2, Kim TH4,…
Evolution of the Pseudomonas aeruginosa aminoglycoside mutational resistome in vitro and in the cystic fibrosis setting.
By fernando | | 0 Comments |
López-Causapé C1, Rubio R2, Cabot G2, Oliver A2. 1 Servicio…
Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: Guidelines by the Spanish Society of Chemotherapy.
By fernando | | 0 Comments |
Mensa J1, Barberán J2, Soriano A1, Llinares P3, Marco F4,…
1 … 21 22 23 24